{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:42:45Z","timestamp":1793148165229,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["JJKH20241344KJ"],"award-info":[{"award-number":["JJKH20241344KJ"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202401239ZYTS"],"award-info":[{"award-number":["YDZJ202401239ZYTS"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cellsig.2025.112335","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:56:03Z","timestamp":1766159763000},"page":"112335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["N-\u03b1-Acetyltransferase 40 promotes oral squamous cell carcinoma progression by enhancing FEN1 transcription and suppressing CD8+ T cell antitumor immunity"],"prefix":"10.1016","volume":"139","author":[{"given":"Kun","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liou","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 2","key":"10.1016\/j.cellsig.2025.112335_bb0005","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.semcancer.2018.01.008","article-title":"Head and neck squamous cell carcinoma: genomics and emerging biomarkers for immunomodulatory cancer treatments","volume":"52","author":"Solomon","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"19","key":"10.1016\/j.cellsig.2025.112335_bb0010","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157649","article-title":"TDO2+ myofibroblasts mediate immune suppression in malignant transformation of squamous cell carcinoma","volume":"132","author":"Hu","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112335_bb0015","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/hed.25640","article-title":"Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: final analysis of a phase 2 clinical trial","volume":"41","author":"Yen","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.cellsig.2025.112335_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebiom.2019.08.013","article-title":"Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma","volume":"47","author":"Yang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cellsig.2025.112335_bb0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ebiom.2018.09.040","article-title":"PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-alpha and-gamma via IRF1 induction","volume":"36","author":"Colli","year":"2018","journal-title":"EBioMedicine"},{"issue":"6477","key":"10.1016\/j.cellsig.2025.112335_bb0030","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax0182","article-title":"Neoadjuvant checkpoint blockade for cancer immunotherapy","volume":"367","author":"Topalian","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0035","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1038\/s41467-019-12319-x","article-title":"Tissue-resident memory CD8(+) T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells","volume":"10","author":"Menares","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1158\/1078-0432.CCR-20-2166","article-title":"An immune-related gene prognostic index for head and neck squamous cell carcinoma","volume":"27","author":"Chen","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112335_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2019.09.011","article-title":"Translational genomics and recent advances in oral squamous cell carcinoma","volume":"61","author":"Chai","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112335_bb0050","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1158\/1078-0432.CCR-15-2834","article-title":"Pan-cancer immunogenomic perspective on the tumor microenvironment based on PD-L1 and CD8 T-cell infiltration","volume":"22","author":"Ock","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/cam4.1889","article-title":"Tumor-infiltrating CD8(+) T-cell density is an independent prognostic marker for oral squamous cell carcinoma","volume":"8","author":"Shimizu","year":"2019","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112335_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024713","article-title":"The human N-alpha-acetyltransferase 40 (hNaa40p\/hNatD) is conserved from yeast and N-terminally acetylates histones H2A and H4","volume":"6","author":"Hole","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0065","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41467-025-55960-5","article-title":"Illuminating the impact of N-terminal acetylation: from protein to physiology","volume":"16","author":"McTiernan","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13072-025-00608-3","article-title":"H2A.X N-terminal acetylation is a newly identified NAA40-mediated modification that is responsive to UV irradiation","volume":"18","author":"Klavaris","year":"2025","journal-title":"Epigenetics Chromatin"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112335_bb0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41419-019-1487-3","article-title":"NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression","volume":"10","author":"Demetriadou","year":"2019","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112335_bb0080","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41388-021-02113-9","article-title":"Histone N-terminal acetyltransferase NAA40 links one-carbon metabolism to chemoresistance","volume":"41","author":"Demetriadou","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.62347\/UGPH7404","article-title":"Exploring the role of NAA40 in immune infiltrates and prognostic prediction in hepatocellular carcinoma","volume":"13","author":"Zhou","year":"2024","journal-title":"Am. J. Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0090","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41467-017-00988-5","article-title":"NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate slug expression","volume":"8","author":"Ju","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112335_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108840","article-title":"NatD epigenetically activates FOXA2 expression to promote breast cancer progression by facilitating MMP14 expression","volume":"27","author":"Xing","year":"2024","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112335_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113937","article-title":"DDX3 regulates cancer immune surveillance via 3\u2019 UTR-mediated cell-surface expression of PD-L1","volume":"43","author":"Chen","year":"2024","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41368-023-00221-8","article-title":"Down-regulation of DNA key protein-FEN1 inhibits OSCC growth by affecting immunosuppressive phenotypes via IFN-gamma\/JAK\/STAT-1","volume":"15","author":"Wang","year":"2023","journal-title":"Int. J. Oral Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0110","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s42003-024-06212-7","article-title":"N(alpha)-acetyltransferase 40-mediated histone acetylation plays an important role in ecdysone regulation of metamorphosis in the red flour beetle, Tribolium castaneum","volume":"7","author":"Gaddelapati","year":"2024","journal-title":"Commun. Biol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112335_bb0115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tibs.2012.02.003","article-title":"Protein N-terminal acetyltransferases: when the start matters","volume":"37","author":"Starheim","year":"2012","journal-title":"Trends Biochem. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112335_bb0120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12967-023-04825-w","article-title":"AIM2 promotes irradiation resistance, migration ability and PD-L1 expression through STAT1\/NF-kappaB activation in oral squamous cell carcinoma","volume":"22","author":"Chiu","year":"2024","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112335_bb0130","article-title":"TLR9 activation induces immunosuppression and tumorigenesis via PARP1\/PD-L1 signaling pathway in oral squamous cell carcinoma","volume":"326","author":"Ma","year":"2024","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.cellsig.2025.112335_bb0135","doi-asserted-by":"crossref","first-page":"6149558","DOI":"10.1155\/2021\/6149558","article-title":"METTL3 intensifies the progress of oral squamous cell carcinoma via modulating the m6A amount of PRMT5 and PD-L1","volume":"2021","author":"Ai","year":"2021","journal-title":"J Immunol Res"},{"issue":"7","key":"10.1016\/j.cellsig.2025.112335_bb0140","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/cbin.11581","article-title":"CircKRT1 drives tumor progression and immune evasion in oral squamous cell carcinoma by sponging miR-495-3p to regulate PDL1 expression","volume":"45","author":"Yang","year":"2021","journal-title":"Cell Biol. Int."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112335_bb0145","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1002\/cam4.5310","article-title":"Cisplatin-induced HSF1-HSP90 axis enhances the expression of functional PD-L1 in oral squamous cell carcinoma","volume":"12","author":"Sasaya","year":"2023","journal-title":"Cancer Med."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112335_bb0150","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1002\/cam4.1675","article-title":"Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin-specific peptidase 9, X-linked in oral squamous cell carcinoma","volume":"7","author":"Jingjing","year":"2018","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112335_bb0155","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/jop.13485","article-title":"Combination of downregulating FEN1 and PD-1 blockade enhances antitumor activity of CD8+ T cells against HNSCC cells in vitro","volume":"52","author":"Wang","year":"2023","journal-title":"J. Oral Pathol. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0160","first-page":"116","article-title":"MiR-26a-5p heightens breast cancer cell sensitivity to paclitaxel via targeting flap endonuclease 1","volume":"53","author":"Cai","year":"2023","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3892\/or.2020.7844","article-title":"MicroRNA-134-3p inhibits ovarian cancer progression by targeting flap structure-specific endonuclease 1 in vitro","volume":"45","author":"Zhao","year":"2021","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112335_bb0170","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.3892\/mmr.2020.11552","article-title":"miR-140-5p inhibits cervical cancer cell phenotypes via downregulating FEN1 to halt the cell cycle","volume":"22","author":"Guo","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellsig.2025.112335_bb0175","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.2147\/OTT.S219977","article-title":"miR-193b increases the chemosensitivity of osteosarcoma cells by promoting FEN1-mediated autophagy","volume":"12","author":"Dong","year":"2019","journal-title":"Targets Ther"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112335_bb0180","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/cas.13660","article-title":"HNRNPLL stabilizes mRNA for DNA replication proteins and promotes cell cycle progression in colorectal cancer cells","volume":"109","author":"Sakuma","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellsig.2025.112335_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.578816","article-title":"IGF2BP2 promotes liver cancer growth through an m6A-FEN1-dependent mechanism","volume":"10","author":"Pu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2025.112335_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2020.102953","article-title":"PRMT1 is critical to FEN1 expression and drug resistance in lung cancer cells","volume":"95","author":"He","year":"2020","journal-title":"DNA Repair (Amst)"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112335_bb0195","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1158\/1535-7163.MCT-18-1215","article-title":"Inhibition of AKT sensitizes cancer cells to antineoplastic drugs by downregulating flap endonuclease 1","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0200","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajpath.2017.09.011","article-title":"Overexpression of flap endonuclease 1 correlates with enhanced proliferation and poor prognosis of non-small-cell lung cancer","volume":"188","author":"Zhang","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112335_bb0205","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/1878-0261.12118","article-title":"FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer","volume":"11","author":"He","year":"2017","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112335_bb0210","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3892\/ijmm.2014.1682","article-title":"Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis","volume":"33","author":"Wang","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112335_bb0215","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.apsb.2024.10.016","article-title":"Tumor-intrinsic PRMT5 upregulates FGL1 via methylating TCF12 to inhibit CD8(+) T-cell-mediated antitumor immunity in liver cancer","volume":"15","author":"Sun","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112335_bb0220","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol. Cell"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:00:12Z","timestamp":1770494412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825007508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":44,"alternative-id":["S0898656825007508"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112335","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-\u03b1-Acetyltransferase 40 promotes oral squamous cell carcinoma progression by enhancing FEN1 transcription and suppressing CD8+ T cell antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112335"}}